EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.4.5 | 2-beta-D-ribofuranosyl-1,2,4-triazol-3-one | - |
Mus musculus | |
3.5.4.5 | 6-thioguanine | - |
Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.5 | cytidine + H2O | Mus musculus | - |
uridine + NH3 | - |
? | |
3.5.4.5 | cytidine + H2O | Mus musculus BALB/c | - |
uridine + NH3 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.4.5 | Mus musculus | - |
mouse | - |
3.5.4.5 | Mus musculus | - |
BALB/c | - |
3.5.4.5 | Mus musculus BALB/c | - |
BALB/c | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.4.5 | kidney | - |
Mus musculus | - |
EC Number | Storage Stability | Organism |
---|---|---|
3.5.4.5 | -20°C, 0.005 M dithiothreitol, enzymatic activity is stable for many weeks | Mus musculus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.4.5 | 1-beta-D-arabinofuranosylcytosine + H2O | araC, most effective agent in therapy of acute myeloblastic leukemia | Mus musculus | ? | - |
? | |
3.5.4.5 | 2',5'-anhydroarabinosylcytosine + H2O | - |
Mus musculus | 2',5'-anhydroarabinosyluracil + NH3 | - |
? | |
3.5.4.5 | 2',5'-anhydroarabinosylcytosine + H2O | - |
Mus musculus BALB/c | 2',5'-anhydroarabinosyluracil + NH3 | - |
? | |
3.5.4.5 | 5'-bromoarabinosylcytosine + H2O | - |
Mus musculus | 5'-bromoarabinosyluracil + NH3 | - |
? | |
3.5.4.5 | 5'-chloroarabinosylcytosine + H2O | - |
Mus musculus | 5'-chloroarabinosyluracil + NH3 | - |
? | |
3.5.4.5 | cytidine + H2O | - |
Mus musculus | uridine + NH3 | - |
? | |
3.5.4.5 | cytidine + H2O | - |
Mus musculus BALB/c | uridine + NH3 | - |
? | |
3.5.4.5 | cytosine arabinoside + H2O | - |
Mus musculus | uridine arabinoside + NH3 | - |
? | |
3.5.4.5 | cytosine arabinoside + H2O | - |
Mus musculus BALB/c | uridine arabinoside + NH3 | - |
? | |
3.5.4.5 | additional information | cyclocytidine, N-4-acetylarabinosylcytosine, tetraacetylarabinosylcytosine, N4-behenoylarabinosylcytosine and tri-O-acetylarabinosylcytosine are no substrates | Mus musculus | ? | - |
? | |
3.5.4.5 | additional information | cyclocytidine, N-4-acetylarabinosylcytosine, tetraacetylarabinosylcytosine, N4-behenoylarabinosylcytosine and tri-O-acetylarabinosylcytosine are no substrates | Mus musculus BALB/c | ? | - |
? | |
3.5.4.5 | N-4-monoacetylarabinosylcytosine | - |
Mus musculus | uracil arabinoside + carbamate | - |
? | |
3.5.4.5 | N-4-monoacetylarabinosylcytosine | - |
Mus musculus BALB/c | uracil arabinoside + carbamate | - |
? |